Retatrutide
GIP / GLP-1 / Glucagon Receptor Triple Agonist
Product Photo
Research Overview
Retatrutide is a long-acting, unimolecular peptide engineered to activate the GIP, GLP-1, and glucagon receptors simultaneously. Its triple-agonist mechanism has made it a focal point of recent metabolic research, particularly studies examining energy expenditure, glycemic control, and body-composition outcomes.
Common Research Applications
- Triple-receptor (GIP/GLP-1/glucagon) agonism research
- Energy expenditure and metabolic rate studies
- Glycemic control research
- Body composition research models
Available Sizes & Pricing
Every order includes a complimentary 3mL vial of bacteriostatic (BAC) water at no extra cost.
Retatrutide questions
What purity does KYIN Peptides' Retatrutide meet?
KYIN Peptides' Retatrutide is independently tested to >99% purity, with a certificate of analysis available upon request for every batch.
Does a Retatrutide order include bacteriostatic (BAC) water?
Yes — every order includes a complimentary 3mL vial of bacteriostatic water at no extra cost.
Is Retatrutide approved for human or clinical use?
No. Retatrutide is sold strictly for laboratory research use and is not approved, evaluated, or intended for human or animal consumption, diagnostic, or therapeutic use.
Related Products
MOTS-c
Mitochondrial-derived peptide studied for its role in metabolic regulation research.
Interested in Retatrutide?
Contact us to place an order or ask about bulk pricing.